Light chain cardiac amyloidosis in a nonagenarian  

作　　者：Koji Takahashi Mina Yamashita Tomoki Sakaue Daijiro Enomoto Shigeki Uemura Takafumi Okura Shuntaro Ikeda Takanori Senba Akira Saijo Nobuhisa Yamamura Sohei Kitazawa 

机构地区：[1]Department of Community Emergency Medicine,Ehime University Graduate School of Medicine,Ehime,Japan [2]Department of Cardiology,Yawatahama City General Hospital,Ehime,Japan [3]Department of Hematology,Yawatahama City General Hospital,Ehime,Japan [4]Department of Clinical Pathology,Yawatahama City General Hospital,Ehime,Japan [5]Department of Molecular Pathology,Ehime University Graduate School of Medicine,Ehime,Japan

出　　处：《Journal of Geriatric Cardiology》2022年第1期83-89,共7页老年心脏病学杂志（英文版）

摘　　要：Cardiac amyloidosis is an infiltrative and restrictive cardiomyopathy caused by the extracellular deposition of amyloid fib-rils within the heart as systemic amyloidosis,lead-ing to heart failure,reduced quality of life,and death.[1]There are two major amyloid fibril proteins that af-fect the heart:amyloid immunoglobulin light chain(AL)and amyloid transthyretin(ATTR).The latter is further subdivided into wild-type ATTR and variant types based on the presence of a mutation in the transthyretin gene.

关 键 词：AMYLOID death. CARDIOMYOPATHY 

分 类 号：R542.2[医药卫生—心血管疾病]